Medication info

Furanizole Injection (Metronidazole)

Prescription medication
Ingredient · strength
Metronidazole›500mg / 1 bottle
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
Colorless and transparent liquid contained in a clear glass or polypropylene container.
Packaging
100mL/bottle
Approval status
Active

MFDS item code 199900910 · Notified 1999.10.02 · Insurance code 652601573

Summary

Main use
Treatment of anaerobic bacterial infections and protozoal infections (trichomoniasis, amebiasis); prevention of postoperative infections
Who uses it
Adults · Children
Adult dosage
(Tablets) Trichomoniasis: The usual adult dose is 250 mg of metronidazole orally twice daily for 10 days. Treatment of anaerobic bacterial infections: The usual adult dose is 500 mg of this medicine orally 3 ∼ 4 times daily. Do not exceed a maximum daily dose of 4 g; treatment generally lasts 7 ∼ 10 days. Postoperative prophylaxis of anaerobic bacterial infections: The usual adult initial dose is 1 g of this medicine, followed by 250 mg orally 3 times daily. Amebiasis: The usual adult dose is 500 ∼ 750 mg of this medicine orally 3 times daily for 5 ~ 10 days. (Injection) Administer the following doses slowly by intravenous injection at a rate of 25 mg (5 mL) per minute. When the patient's condition improves, switch to oral treatment as soon as possible. Treatment of anaerobic bacterial infections — Adults: Administer 500 mg (100 mL) of metronidazole intravenously every 8 hours. When oral administration becomes possible, switch to oral metronidazole 500 mg 3 times daily. The total duration of injectable treatment should not exceed 7 days, although extension of treatment may be considered based on clinical and bacteriological evaluation. Prevention of postoperative infections caused by anaerobic bacteria (use of this regimen is generally limited to 24 hours, and no more than 48 hours) — Adults: Administer 500 mg (100 mL) of this medicine intravenously every 8 hours immediately before, during, or after surgery. When oral administration becomes possible, switch to oral metronidazole 250 mg 3 times daily.
Children's dosage
Treatment of anaerobic bacterial infections — Children aged 12 years and older: Administer 500 mg (100 mL) of metronidazole intravenously every 8 hours. When oral administration becomes possible, switch to oral metronidazole 500 mg 3 times daily. The total duration of injectable treatment should not exceed 7 days, although extension of treatment may be considered based on clinical and bacteriological evaluation. Treatment of anaerobic bacterial infections — Children younger than 12 years: Administer 3 times daily. The intravenous dose per administration is 7.5 mg (1.5 mL) of this medicine per kg of body weight, and the oral dose per administration is also 7.5 mg of metronidazole per kg of body weight. Treatment of anaerobic bacterial infections — Infants younger than 8 weeks: Administer twice daily. Prevention of postoperative infections caused by anaerobic bacteria — Children aged 12 years and older: Administer 500 mg (100 mL) of this medicine intravenously every 8 hours immediately before, during, or after surgery. When oral administration becomes possible, switch to oral metronidazole 250 mg 3 times daily. Prevention of postoperative infections caused by anaerobic bacteria — Children younger than 12 years: The preoperative intravenous dose is 20~30mg of this medicine per kg of body weight as a single dose. Prevention of postoperative infections caused by anaerobic bacteria — Premature infants: The preoperative intravenous dose is 10mg of this medicine per kg of body weight as a single dose.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Treatment of anaerobic bacterial infections and protozoal infections (trichomoniasis, amebiasis); prevention of postoperative infections

  • Trichomoniasis
  • anaerobic bacterial infections
  • intra-abdominal infections
  • peritonitis
  • intra-abdominal abscess
  • liver abscess
  • skin and soft tissue infections
  • gynecological infections
  • endometritis
  • myometritis
  • ovarian abscess
  • bacterial sepsis
View approved original text

This medicine is effective in treating parasitic infections such as trichomoniasis and amoebiasis. It is also used for various anaerobic bacterial infections, and helps treat peritonitis, liver abscess, skin and soft tissue infections, gynecological infections such as endometritis and myometritis, ovarian abscesses, bone and joint infections, central nervous system infections such as brain abscess and meningitis, lower respiratory infections such as pneumonia, and several severe infections including endocarditis. It is particularly important for preventing anaerobic infections that can occur after surgery. This drug is effective against anaerobic bacterioides and streptococci and improves various infectious conditions such as sepsis, abscesses, and necrotizing pneumonia. It is a reliable medicine used in the treatment and prevention of such diverse infectious diseases.

Dosage and Administration

Adult dosage

(Tablets) Trichomoniasis: The usual adult dose is 250 mg of metronidazole orally twice daily for 10 days. Treatment of anaerobic bacterial infections: The usual adult dose is 500 mg of this medicine orally 3 ∼ 4 times daily. Do not exceed a maximum daily dose of 4 g; treatment generally lasts 7 ∼ 10 days. Postoperative prophylaxis of anaerobic bacterial infections: The usual adult initial dose is 1 g of this medicine, followed by 250 mg orally 3 times daily. Amebiasis: The usual adult dose is 500 ∼ 750 mg of this medicine orally 3 times daily for 5 ~ 10 days. (Injection) Administer the following doses slowly by intravenous injection at a rate of 25 mg (5 mL) per minute. When the patient's condition improves, switch to oral treatment as soon as possible. Treatment of anaerobic bacterial infections — Adults: Administer 500 mg (100 mL) of metronidazole intravenously every 8 hours. When oral administration becomes possible, switch to oral metronidazole 500 mg 3 times daily. The total duration of injectable treatment should not exceed 7 days, although extension of treatment may be considered based on clinical and bacteriological evaluation. Prevention of postoperative infections caused by anaerobic bacteria (use of this regimen is generally limited to 24 hours, and no more than 48 hours) — Adults: Administer 500 mg (100 mL) of this medicine intravenously every 8 hours immediately before, during, or after surgery. When oral administration becomes possible, switch to oral metronidazole 250 mg 3 times daily.

Children's dosage

Treatment of anaerobic bacterial infections — Children aged 12 years and older: Administer 500 mg (100 mL) of metronidazole intravenously every 8 hours. When oral administration becomes possible, switch to oral metronidazole 500 mg 3 times daily. The total duration of injectable treatment should not exceed 7 days, although extension of treatment may be considered based on clinical and bacteriological evaluation. Treatment of anaerobic bacterial infections — Children younger than 12 years: Administer 3 times daily. The intravenous dose per administration is 7.5 mg (1.5 mL) of this medicine per kg of body weight, and the oral dose per administration is also 7.5 mg of metronidazole per kg of body weight. Treatment of anaerobic bacterial infections — Infants younger than 8 weeks: Administer twice daily. Prevention of postoperative infections caused by anaerobic bacteria — Children aged 12 years and older: Administer 500 mg (100 mL) of this medicine intravenously every 8 hours immediately before, during, or after surgery. When oral administration becomes possible, switch to oral metronidazole 250 mg 3 times daily. Prevention of postoperative infections caused by anaerobic bacteria — Children younger than 12 years: The preoperative intravenous dose is 20~30mg of this medicine per kg of body weight as a single dose. Prevention of postoperative infections caused by anaerobic bacteria — Premature infants: The preoperative intravenous dose is 10mg of this medicine per kg of body weight as a single dose.

Precautions

This drug should be avoided due to reports of tumor formation in rodent experiments. Systemic administration of this drug in patients with cocaine syndrome may cause severe hepatotoxicity or acute liver failure; therefore, liver function tests must be conducted and cautious usage is required. It should not be administered to patients who are allergic to this drug or its components, those with a history of blood disorders or neurological disorders, mothers in the first trimester of pregnancy, or those taking certain medications. Also, severe side effects may occur when consumed with alcohol, so alcohol should be avoided for at least 3 days during and after treatment. Extra caution is needed for patients with liver dysfunction or pregnant women in the later stages, CNS infection patients, and those requiring sodium restrictions. Various side effects may occur in the digestive system, blood system, skin, and nervous system; therefore, if abnormal symptoms arise, medical personnel should be notified immediately. Patients with severe liver disease may need dosage adjustment as the drug can accumulate in the body, and regular clinical evaluations during treatment are recommended. This drug may affect blood clotting; therefore, patients taking anticoagulants need blood testing and dosage adjustments. There are many interactions with other medications, so inform your doctor or pharmacist if you are taking other drugs, especially avoiding concomitant use with alcohol, disulfiram, and certain antiepileptics. During pregnancy, this medication may affect the fetus; hence, it should not be used in the early months of pregnancy, and nursing should be discontinued while using this drug. In case of overdose, no specific antidote exists, usual treatment will be administered, and this drug should not be mixed with other drugs but is to be used solely for intravenous drip injection. Any remaining drug after usage should be discarded, and if adverse skin reactions occur during administration, the treatment should be stopped immediately.

Side effects

Elevated serum amylase, upper abdominal pain, nausea, vomiting, diarrhea, oral mucositis, taste disturbance, anorexia, reversible pancreatitis, leukopenia, neutropenia, agranulocytosis, thrombocytopenia, rash, itching, flushing, urticaria, fever, angioedema, anaphylactic shock, pustular rash, erythema multiforme, aseptic meningitis, headache, seizures, dizziness, ataxia, syncope, convulsive seizures, peripheral sensory neuropathy, encephalopathy, confusion, subacute cerebellar syndrome, ataxia, speech disorders, gait disorders, eye tremors, tremors, venous thromboembolism, mental disorders, feelings of depression, diplopia, myopia, optic neuropathy, elevated liver enzyme levels, cholestasis, hepatitis, jaundice, mucocutaneous syndrome, toxic epidermal necrolysis, eosinophilia, drug reaction, acute generalised exanthematous pustulosis, vesicular dermatitis, fixed drug eruption, hearing impairment, hearing loss, tinnitus, fever, drowsiness, glossitis, dry lips, reddish-brown urine, arthralgia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container, avoiding direct sunlight and kept in a cool place. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature, and refrigeration is not necessary. Proper storage will help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

Colorless and transparent liquid contained in a clear glass or polypropylene container.

Package unit

100mL/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.